Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Detection of Antibodies to Spotted Fever Group Rickettsiae and Arboviral Coinfections in Febrile Individuals in 2014-2015 in Southern Coastal Ecuador.

Farovitch L, Sippy R, Beltrán-Ayala E, Endy TP, Stewart-Ibarra AM, Leydet BF.

Am J Trop Med Hyg. 2019 Sep 23. doi: 10.4269/ajtmh.19-0157. [Epub ahead of print]

PMID:
31549616
2.

Longitudinal Analysis of Memory B and T Cell Responses to Dengue Virus in a 5-Year Prospective Cohort Study in Thailand.

Sánchez-Vargas LA, Kounlavouth S, Smith ML, Anderson KB, Srikiatkhachorn A, Ellison DW, Currier JR, Endy TP, Mathew A, Rothman AL.

Front Immunol. 2019 Jun 13;10:1359. doi: 10.3389/fimmu.2019.01359. eCollection 2019.

3.

Protective versus pathologic pre-exposure cytokine profiles in dengue virus infection.

Friberg H, Beaumier CM, Park S, Pazoles P, Endy TP, Mathew A, Currier JR, Jarman RG, Anderson KB, Hatch S, Thomas SJ, Rothman AL.

PLoS Negl Trop Dis. 2018 Dec 17;12(12):e0006975. doi: 10.1371/journal.pntd.0006975. eCollection 2018 Dec.

4.

Chagas Disease in Southern Coastal Ecuador: Coinfections with Arboviruses and a Comparison of Serological Assays for Chagas Disease Diagnosis.

Mita-Mendoza NK, McMahon E, Kenneson A, Barbachano-Guerrero A, Beltran-Ayala E, Cueva C, King CA, Lupone CD, Castro-Sesquen YE, Gilman RH, Endy TP, Stewart-Ibarra AM.

Am J Trop Med Hyg. 2018 Dec;99(6):1530-1533. doi: 10.4269/ajtmh.18-0441. Epub 2018 Oct 18.

PMID:
30350764
5.

The dynamic role of dengue cross-reactive immunity: changing the approach to defining vaccine safety and efficacy.

Anderson KB, Endy TP, Thomas SJ.

Lancet Infect Dis. 2018 Oct;18(10):e333-e338. doi: 10.1016/S1473-3099(18)30126-9. Epub 2018 May 18. Review.

PMID:
29784457
6.

Finding the Signal in the Noise in the Serologic Diagnosis of Flavivirus Infections.

Anderson KB, Endy TP, Thomas SJ.

J Infect Dis. 2018 Jul 13;218(4):516-518. doi: 10.1093/infdis/jiy166. No abstract available.

PMID:
29618090
7.

The Burden of Dengue Fever and Chikungunya in Southern Coastal Ecuador: Epidemiology, Clinical Presentation, and Phylogenetics from the First Two Years of a Prospective Study.

Stewart-Ibarra AM, Ryan SJ, Kenneson A, King CA, Abbott M, Barbachano-Guerrero A, Beltrán-Ayala E, Borbor-Cordova MJ, Cárdenas WB, Cueva C, Finkelstein JL, Lupone CD, Jarman RG, Maljkovic Berry I, Mehta S, Polhemus M, Silva M, Endy TP.

Am J Trop Med Hyg. 2018 May;98(5):1444-1459. doi: 10.4269/ajtmh.17-0762. Epub 2018 Mar 1.

8.

Case Report: An Acute Chikungunya Infection and a Recent Secondary Dengue Infection in a Peripartum Case in Ecuador.

Farrell DF, Lupone CD, Kenneson A, Cueva C, Heydari N, Barzallo Aguilera JH, Polhemus M, Endy TP, Stewart-Ibarra AM.

Am J Trop Med Hyg. 2018 Mar;98(3):838-840. doi: 10.4269/ajtmh.17-0781. Epub 2018 Jan 18.

9.

Social-ecological factors and preventive actions decrease the risk of dengue infection at the household-level: Results from a prospective dengue surveillance study in Machala, Ecuador.

Kenneson A, Beltrán-Ayala E, Borbor-Cordova MJ, Polhemus ME, Ryan SJ, Endy TP, Stewart-Ibarra AM.

PLoS Negl Trop Dis. 2017 Dec 18;11(12):e0006150. doi: 10.1371/journal.pntd.0006150. eCollection 2017 Dec.

10.

The Emergence of Zika Virus: A Narrative Review.

Anderson KB, Thomas SJ, Endy TP.

Ann Intern Med. 2016 Aug 2;165(3):175-83. doi: 10.7326/M16-0617. Epub 2016 May 3. Review.

PMID:
27135717
11.

Improving dengue virus capture rates in humans and vectors in Kamphaeng Phet Province, Thailand, using an enhanced spatiotemporal surveillance strategy.

Thomas SJ, Aldstadt J, Jarman RG, Buddhari D, Yoon IK, Richardson JH, Ponlawat A, Iamsirithaworn S, Scott TW, Rothman AL, Gibbons RV, Lambrechts L, Endy TP.

Am J Trop Med Hyg. 2015 Jul;93(1):24-32. doi: 10.4269/ajtmh.14-0242. Epub 2015 May 18.

12.

Case report: Non-invasive management of Madura foot with oral posaconazole and ciprofloxacin.

Sharma AM, Sharma N, Nat A, Rane M, Endy TP.

Am J Trop Med Hyg. 2014 Dec;91(6):1259-62. doi: 10.4269/ajtmh.14-0335. Epub 2014 Oct 27.

13.

Dengue virus neutralizing antibody levels associated with protection from infection in thai cluster studies.

Buddhari D, Aldstadt J, Endy TP, Srikiatkhachorn A, Thaisomboonsuk B, Klungthong C, Nisalak A, Khuntirat B, Jarman RG, Fernandez S, Thomas SJ, Scott TW, Rothman AL, Yoon IK.

PLoS Negl Trop Dis. 2014 Oct 16;8(10):e3230. doi: 10.1371/journal.pntd.0003230. eCollection 2014 Oct.

14.

Micronutrients and dengue.

Ahmed S, Finkelstein JL, Stewart AM, Kenneth J, Polhemus ME, Endy TP, Cardenas W, Mehta S.

Am J Trop Med Hyg. 2014 Nov;91(5):1049-56. doi: 10.4269/ajtmh.14-0142. Epub 2014 Sep 8. Review.

15.

Dengue human infection model performance parameters.

Endy TP.

J Infect Dis. 2014 Jun 15;209 Suppl 2:S56-60. doi: 10.1093/infdis/jiu112.

16.

Human immune responses to dengue virus infection: lessons learned from prospective cohort studies.

Endy TP.

Front Immunol. 2014 Apr 24;5:183. doi: 10.3389/fimmu.2014.00183. eCollection 2014. Review.

17.

Characteristics of mild dengue virus infection in Thai children.

Yoon IK, Srikiatkhachorn A, Hermann L, Buddhari D, Scott TW, Jarman RG, Aldstadt J, Nisalak A, Thammapalo S, Bhoomiboonchoo P, Mammen MP, Green S, Gibbons RV, Endy TP, Rothman AL.

Am J Trop Med Hyg. 2013 Dec;89(6):1081-7. doi: 10.4269/ajtmh.13-0424. Epub 2013 Oct 14.

18.

Field detection of Tembusu virus in western Thailand by rt-PCR and vector competence determination of select culex mosquitoes for transmission of the virus.

O'Guinn ML, Turell MJ, Kengluecha A, Jaichapor B, Kankaew P, Miller RS, Endy TP, Jones JW, Coleman RE, Lee JS.

Am J Trop Med Hyg. 2013 Nov;89(5):1023-8. doi: 10.4269/ajtmh.13-0160. Epub 2013 Sep 16.

19.

A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a school-based cohort in Thailand.

Anderson KB, Gibbons RV, Cummings DA, Nisalak A, Green S, Libraty DH, Jarman RG, Srikiatkhachorn A, Mammen MP, Darunee B, Yoon IK, Endy TP.

J Infect Dis. 2014 Feb 1;209(3):360-8. doi: 10.1093/infdis/jit436. Epub 2013 Aug 20.

20.

Current issues in dengue vaccination.

Thomas SJ, Endy TP.

Curr Opin Infect Dis. 2013 Oct;26(5):429-34. doi: 10.1097/01.qco.0000433310.28771.cc. Review.

PMID:
23963259
21.

A model international partnership for community-based research on vaccine-preventable diseases: the Kamphaeng Phet-AFRIMS Virology Research Unit (KAVRU).

Gibbons RV, Nisalak A, Yoon IK, Tannitisupawong D, Rungsimunpaiboon K, Vaughn DW, Endy TP, Innis BL, Burke DS, Mammen MP Jr, Scott RM, Thomas SJ, Hoke CH Jr.

Vaccine. 2013 Sep 23;31(41):4487-500. doi: 10.1016/j.vaccine.2013.07.082. Epub 2013 Aug 8. Review.

PMID:
23933334
22.

Frequent in-migration and highly focal transmission of dengue viruses among children in Kamphaeng Phet, Thailand.

Rabaa MA, Klungthong C, Yoon IK, Holmes EC, Chinnawirotpisan P, Thaisomboonsuk B, Srikiatkhachorn A, Rothman AL, Tannitisupawong D, Aldstadt J, Nisalak A, Mammen MP, Gibbons RV, Endy TP, Fansiri T, Scott TW, Jarman RG.

PLoS Negl Trop Dis. 2013;7(1):e1990. doi: 10.1371/journal.pntd.0001990. Epub 2013 Jan 17.

23.

Dengue viral RNA levels in peripheral blood mononuclear cells are associated with disease severity and preexisting dengue immune status.

Srikiatkhachorn A, Wichit S, Gibbons RV, Green S, Libraty DH, Endy TP, Ennis FA, Kalayanarooj S, Rothman AL.

PLoS One. 2012;7(12):e51335. doi: 10.1371/journal.pone.0051335. Epub 2012 Dec 19.

24.

Revealing the microscale spatial signature of dengue transmission and immunity in an urban population.

Salje H, Lessler J, Endy TP, Curriero FC, Gibbons RV, Nisalak A, Nimmannitya S, Kalayanarooj S, Jarman RG, Thomas SJ, Burke DS, Cummings DA.

Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9535-8. doi: 10.1073/pnas.1120621109. Epub 2012 May 29.

25.

Preexisting Japanese encephalitis virus neutralizing antibodies and increased symptomatic dengue illness in a school-based cohort in Thailand.

Anderson KB, Gibbons RV, Thomas SJ, Rothman AL, Nisalak A, Berkelman RL, Libraty DH, Endy TP.

PLoS Negl Trop Dis. 2011 Oct;5(10):e1311. doi: 10.1371/journal.pntd.0001311. Epub 2011 Oct 4.

26.

Emerging infectious diseases as a global health threat. Introduction.

Endy TP, Rochford R, Yuen KY, Lei HY.

Exp Biol Med (Maywood). 2011 Aug;236(8):897-8. doi: 10.1258/ebm.2011.011i01. No abstract available.

PMID:
21821661
27.

Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus-naive infants.

Watanaveeradej V, Simasathien S, Nisalak A, Endy TP, Jarman RG, Innis BL, Thomas SJ, Gibbons RV, Hengprasert S, Samakoses R, Kerdpanich A, Vaughn DW, Putnak JR, Eckels KH, Barrera Rde L, Mammen MP Jr.

Am J Trop Med Hyg. 2011 Aug;85(2):341-51. doi: 10.4269/ajtmh.2011.10-0501.

28.

Critical issues in dengue vaccine development.

Thomas SJ, Endy TP.

Curr Opin Infect Dis. 2011 Oct;24(5):442-50. doi: 10.1097/QCO.0b013e32834a1b0b. Review.

PMID:
21799408
29.

Vaccines for the prevention of dengue: development update.

Thomas SJ, Endy TP.

Hum Vaccin. 2011 Jun;7(6):674-84. Epub 2011 Jun 1. Review.

PMID:
21508679
30.

Determinants of inapparent and symptomatic dengue infection in a prospective study of primary school children in Kamphaeng Phet, Thailand.

Endy TP, Anderson KB, Nisalak A, Yoon IK, Green S, Rothman AL, Thomas SJ, Jarman RG, Libraty DH, Gibbons RV.

PLoS Negl Trop Dis. 2011 Mar 1;5(3):e975. doi: 10.1371/journal.pntd.0000975.

31.

Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection.

Hatch S, Endy TP, Thomas S, Mathew A, Potts J, Pazoles P, Libraty DH, Gibbons R, Rothman AL.

J Infect Dis. 2011 May 1;203(9):1282-91. doi: 10.1093/infdis/jir012. Epub 2011 Feb 18.

32.

Classification of dengue illness based on readily available laboratory data.

Potts JA, Thomas SJ, Srikiatkhachorn A, Supradish PO, Li W, Nisalak A, Nimmannitya S, Endy TP, Libraty DH, Gibbons RV, Green S, Rothman AL, Kalayanarooj S.

Am J Trop Med Hyg. 2010 Oct;83(4):781-8. doi: 10.4269/ajtmh.2010.10-0135.

33.

Inferring the serotype associated with dengue virus infections on the basis of pre- and postinfection neutralizing antibody titers.

van Panhuis WG, Gibbons RV, Endy TP, Rothman AL, Srikiatkhachorn A, Nisalak A, Burke DS, Cummings DA.

J Infect Dis. 2010 Oct 1;202(7):1002-10. doi: 10.1086/656141.

34.

An outbreak of Plasmodium falciparum malaria in U.S. Marines deployed to Liberia.

Whitman TJ, Coyne PE, Magill AJ, Blazes DL, Green MD, Milhous WK, Burgess TH, Freilich D, Tasker SA, Azar RG, Endy TP, Clagett CD, Deye GA, Shanks GD, Martin GJ.

Am J Trop Med Hyg. 2010 Aug;83(2):258-65. doi: 10.4269/ajtmh.2010.09-0774.

35.

Memory CD8+ T cells from naturally acquired primary dengue virus infection are highly cross-reactive.

Friberg H, Burns L, Woda M, Kalayanarooj S, Endy TP, Stephens HA, Green S, Rothman AL, Mathew A.

Immunol Cell Biol. 2011 Jan;89(1):122-9. doi: 10.1038/icb.2010.61. Epub 2010 Apr 27.

36.

Dengue hemorrhagic fever: the sensitivity and specificity of the world health organization definition for identification of severe cases of dengue in Thailand, 1994-2005.

Srikiatkhachorn A, Gibbons RV, Green S, Libraty DH, Thomas SJ, Endy TP, Vaughn DW, Nisalak A, Ennis FA, Rothman AL, Nimmannitaya S, Kalayanarooj S.

Clin Infect Dis. 2010 Apr 15;50(8):1135-43. doi: 10.1086/651268.

37.

Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: How alterations in assay conditions impact performance.

Thomas SJ, Nisalak A, Anderson KB, Libraty DH, Kalayanarooj S, Vaughn DW, Putnak R, Gibbons RV, Jarman R, Endy TP.

Am J Trop Med Hyg. 2009 Nov;81(5):825-33. doi: 10.4269/ajtmh.2009.08-0625.

38.

Prospective cohort studies of dengue viral transmission and severity of disease.

Endy TP, Yoon IK, Mammen MP.

Curr Top Microbiol Immunol. 2010;338:1-13. doi: 10.1007/978-3-642-02215-9_1. Review.

PMID:
19802574
39.

TNF and LTA gene, allele, and extended HLA haplotype associations with severe dengue virus infection in ethnic Thais.

Vejbaesya S, Luangtrakool P, Luangtrakool K, Kalayanarooj S, Vaughn DW, Endy TP, Mammen MP, Green S, Libraty DH, Ennis FA, Rothman AL, Stephens HA.

J Infect Dis. 2009 May 15;199(10):1442-8. doi: 10.1086/597422.

40.

Human metapneumovirus reinfection among children in Thailand determined by ELISA using purified soluble fusion protein.

Pavlin JA, Hickey AC, Ulbrandt N, Chan YP, Endy TP, Boukhvalova MS, Chunsuttiwat S, Nisalak A, Libraty DH, Green S, Rothman AL, Ennis FA, Jarman R, Gibbons RV, Broder CC.

J Infect Dis. 2008 Sep 15;198(6):836-42. doi: 10.1086/591186.

41.

Comparative evaluation of three assays for measurement of dengue virus neutralizing antibodies.

Putnak JR, de la Barrera R, Burgess T, Pardo J, Dessy F, Gheysen D, Lobet Y, Green S, Endy TP, Thomas SJ, Eckels KH, Innis BL, Sun W.

Am J Trop Med Hyg. 2008 Jul;79(1):115-22.

PMID:
18606774
42.

Microevolution of Dengue viruses circulating among primary school children in Kamphaeng Phet, Thailand.

Jarman RG, Holmes EC, Rodpradit P, Klungthong C, Gibbons RV, Nisalak A, Rothman AL, Libraty DH, Ennis FA, Mammen MP Jr, Endy TP.

J Virol. 2008 Jun;82(11):5494-500. doi: 10.1128/JVI.02728-07. Epub 2008 Mar 26.

43.

A comparative study of leptospirosis and dengue in Thai children.

Libraty DH, Myint KS, Murray CK, Gibbons RV, Mammen MP, Endy TP, Li W, Vaughn DW, Nisalak A, Kalayanarooj S, Hospenthal DR, Green S, Rothman AL, Ennis FA.

PLoS Negl Trop Dis. 2007 Dec 26;1(3):e111.

44.

Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences.

Gibbons RV, Kalanarooj S, Jarman RG, Nisalak A, Vaughn DW, Endy TP, Mammen MP Jr, Srikiatkhachorn A.

Am J Trop Med Hyg. 2007 Nov;77(5):910-3.

PMID:
17984352
45.

Development of a TaqMan minor groove binding protein assay for the detection and quantification of Crimean-Congo hemorrhagic fever virus.

Garrison AR, Alakbarova S, Kulesh DA, Shezmukhamedova D, Khodjaev S, Endy TP, Paragas J.

Am J Trop Med Hyg. 2007 Sep;77(3):514-20.

PMID:
17827370
46.

Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study.

Anderson KB, Chunsuttiwat S, Nisalak A, Mammen MP, Libraty DH, Rothman AL, Green S, Vaughn DW, Ennis FA, Endy TP.

Lancet. 2007 Apr 28;369(9571):1452-1459. doi: 10.1016/S0140-6736(07)60671-0.

PMID:
17467515
47.

Antibody-dependent cellular cytotoxicity mediated by plasma obtained before secondary dengue virus infections: potential involvement in early control of viral replication.

Laoprasopwattana K, Libraty DH, Endy TP, Nisalak A, Chunsuttiwat S, Ennis FA, Rothman AL, Green S.

J Infect Dis. 2007 Apr 15;195(8):1108-16. Epub 2007 Mar 7.

PMID:
17357046
48.

Safety and efficacy of a recombinant hepatitis E vaccine.

Shrestha MP, Scott RM, Joshi DM, Mammen MP Jr, Thapa GB, Thapa N, Myint KS, Fourneau M, Kuschner RA, Shrestha SK, David MP, Seriwatana J, Vaughn DW, Safary A, Endy TP, Innis BL.

N Engl J Med. 2007 Mar 1;356(9):895-903.

49.

The study transplacental chikungunya virus antibody kinetics, Thailand.

Watanaveeradej V, Endy TP, Simasathien S, Kerdpanich A, Polprasert N, Aree C, Vaughn DW, Nisalak A.

Emerg Infect Dis. 2006 Nov;12(11):1770-2.

50.

Virus-induced decline in soluble vascular endothelial growth receptor 2 is associated with plasma leakage in dengue hemorrhagic Fever.

Srikiatkhachorn A, Ajariyakhajorn C, Endy TP, Kalayanarooj S, Libraty DH, Green S, Ennis FA, Rothman AL.

J Virol. 2007 Feb;81(4):1592-600. Epub 2006 Dec 6.

Supplemental Content

Support Center